2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92547°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Äí½Ã¸Õ¾Øµå¿þÀÌÅ©Çʵå, ±¹³» À¯ÀÏ °øÀåºÎÁö ¸Å°¢ÆÀ ¿î¿µ (2024-04-18)
Çѱ¹°ü±¤°ø»ç¡¤Çѱ¹Ã¼À°»ê¾÷°³¹ß¡¤Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø ä¿ë (2024-08-07)
¹è¿ì ÀÌÁرâ, 5³â ¸¸ÀÇ ¾Æ½Ã¾Æ Åõ¾î (2024-08-09)
KB½ºÅ¸¹ðÅ· ³» ¡®±¹¹ÎÁö°©¡¯¿¡¼­ ½º¸¶Æ®ÆÐ½º ¼­ºñ½º ÀÌ¿ë (2024-05-29)
ÇüÁö ¾ÆÆ®¸ô¸µ, ¿£ÅÍÅ×ÀÎ¸ÕÆ® Å×³ÍÆ® °­È­ (2024-01-10)
À¯´Ï¼½½º ºê·£µå 'Á¦¸® ÄÚ½ººñ', 24 ½æ¸Ó Ä÷º¼Ç ¡®SEA SIDE¡¯ (2024-06-02)
Pharmanovia Signs Novel Biologic In-Licensing Agreement With... (2024-11-30)
¹ß¸®, ±Û·Î¹ú ¾Ú¹è¼­´õ µµ°â°ú ÇÔ²²ÇÑ È­º¸ (2023-11-11)
Puma Reimagines Modern Retail With Las Vegas Flagship Store ... (2024-12-04)
Çö´ëÂ÷¡¤±â¾Æ, ¡®¿©¸§ Ưº° ¹«»óÁ¡°Ë ¼­ºñ½º¡¯ ½Ç½Ã (2024-07-17)
Åõ½æÇ÷¹À̽º, 5¿ù SKT T day À̺¥Æ® ÁøÇࡦ 35% ÇÒÀÎ Á¦°ø (2024-05-08)
¼¿¸®µå, ±¹³» À¯ÀÏ º¯ÀÌ ´ëÀÀ ¹é½Å °³¹ß·Î ¡®¹é½Å Áֱǡ¯ È®º¸ (2024-07-19)
DN¼Ö·ç¼ÇÁî ±Ý¼Ó 3DÇÁ¸°ÅÍ, ÇØ±º Çʼöǰ µÆ´Ù (2024-07-21)
½º¸¶Æ®Æù Àá½Ã ¸ØÃã, û¼Ò³â ¡®¶Ñ¹÷¶Ñ¹÷ µðÁöÅÐ µðÅ彺¡¯ Ä·ÆäÀÎ (2024-07-23)
¾Ö´ÏÁ¨-ÀϺ» Glytech, ´ç-ÆéŸÀ̵å À§Å¹»ý»ê ¹× °øµ¿°³¹ß (2023-10-21)
KT, ÀÌ¿ø, GSĮŨ½º µî ÇϰèÀÎÅÏ ¸ðÁý Áß (2016-04-07)
NIKE, Inc. Appoints Long-Time Leaders Ann Miller as EVP, Glo... (2024-11-09)
µ¿Åº¿ÍÀÌÄÉÀÌ ÆÛ½ºÆ®Å¸¿ö Áö½Ä»ê¾÷¼¾ÅÍ Áö¿ø»ó°¡ (2016-01-15)
Wa¡¯ed Ventures Leads a US $27 Million Series A Round for Re... (2023-09-01)
ÀÓ¿µ¿õ, ¸¶ÀÌ¿øÇÈ Æ®·ÎÆ® ºÎ¹® 100ÁÖ ¿¬¼Ó 1À§ ´Þ¼º (2024-05-28)
»ï¼ºÀüÀÚ, Å©·¡ÇÁÅæ°ú ¡®´ÙÅ©¾Ø´ÙÄ¿ ¸ð¹ÙÀÏ¡¯ °ÔÀÓ Çù¾÷ (2024-08-04)
GS25, Çѱ¹µµ·Î°ø»ç¿Í ¡®ÈÞ°Ô¼Ò Àαâ À½½Ä¡¯ »óǰȭ MOU (2024-07-10)
ÀÚ¿øºÀ»çȰµ¿ ±âº»¹ý, 20³â°£ ÇÑ ¹øµµ ¹Ù²ï Àû ¾ø¾î (2024-03-02)
¿ì¸®³ª¶óµµ ÇÙ¹«Àå ÇØ¾ß ÇÑ´Ù 51.2% (2013-02-14)
¼¼°è ¾ØÆ²·¯ ÆÝµå ¸Å´ÏÀúµé ¼­¿ï·Î Áý°á (2024-06-11)
       [ÀÌÀü][1]....[591][592][593][594][595][596][597][598][599]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..